| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.5M | — | — |
| R&D Expense | $24.3M | +9.4% | +36.1% |
| SG&A Expense | $7.1M | +3.0% | +45.4% |
| Operating Income | $2.6M | +109.0% | +111.6% |
| Pre-tax Income | $8.2M | +132.9% | +139.6% |
| Income Tax | $0 | — | +100.0% |
| Net Income | $8.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $320.0M | +69.0% | +262.6% |
| Short-term Investments | $154.4M | +12.5% | +265.0% |
| Accounts Receivable | $8.6M | +5625.2% | +4016.7% |
| Current Assets | $491.7M | +47.1% | +268.5% |
| Total Assets | $606.7M | +46.1% | +248.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $125.2M | — | — |
| Capital Expenditures | $453K | — | — |
| Investing Cash Flow | -$44.1M | — | — |
| Financing Cash Flow | $668K | — | — |
| Free Cash Flow | $124.7M | — | — |
| +139.8% |
| EPS (Basic) | $0.18 | +132.1% | +102.1% |
| EPS (Diluted) | $0.18 | +132.1% | +102.1% |
| $75.3M |
| +397.7% |
| +469.0% |
| Total Liabilities | $217.9M | +478.4% | +480.6% |
| Stockholders' Equity | $388.7M | +3.0% | +544.7% |